The Blurring Lines: How Imaging and Clinical Labs Have a Role in Diagnosing AIH
Diagnosing AIH often requires an invasive biopsy. But a new class of imaging allows for non-invasive diagnosis of new and recurring AIH.
Read MorePosted by Chris Wolski | Jun 30, 2022 | Allergy & Autoimmune |
Diagnosing AIH often requires an invasive biopsy. But a new class of imaging allows for non-invasive diagnosis of new and recurring AIH.
Read MorePosted by Andy Lundin | Jun 28, 2022 | Pancreatic |
Pancreatic ductal adenocarcinoma affects more than 90% of patients with pancreatic cancer and has an average 5-year survival rate under 10%.
Read MorePosted by Andy Lundin | Jun 16, 2022 | Diabetes & Metabolic Diseases |
A new test could more accurately predict if individuals who undergo gastric bypass surgery will experience a remission of type 2 diabetes.
Read MorePosted by Andy Lundin | Jun 15, 2022 | Sequencing Systems |
Acutis Diagnostics, a New York State laboratory, is developing advanced gene sequencing technologies that can be used in the clinic.
Read MorePosted by Chris Wolski | Jun 15, 2022 | Disease States |
The diagnosis of congenital CMV in newborns is challenging and impossible to predict. Testing must be completed within 21 days of birth.
Read More